Evidence map›Paper›PMID 27091017›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2016

Recalibration of 24,25-Dihydroxyvitamin D3 Results Based on NIST Standard Reference Material 972a.

Andrew N Hoofnagle, Thomas J Laha, Ian H de Boer

Abstract readLetterComment
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Andrew N HoofnagleUniversity of Washington, Seattle, Washington.
Thomas J LahaUniversity of Washington, Seattle, Washington.
Ian H de BoerUniversity of Washington, Seattle, Washington. Electronic address: deboer@u.washington.edu.

Funding

PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
Phosphorus and Vitamin D Metabolism and Cardiovascular Outcomes: The multi-ethniR01HL096875 · NHLBI · UNIVERSITY OF WASHINGTON · PI DE BOER, IAN H, KESTENBAUM, BRYAN R · 2010 to 2019
$5.2M
Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney diseaseR01DK088762 · NIDDK · UNIVERSITY OF WASHINGTON · PI DE BOER, IAN H · 2010 to 2019
$4.7M
Vitamin D Catabolism in Chronic Kidney DiseaseR01DK099199 · NIDDK · UNIVERSITY OF WASHINGTON · PI DE BOER, IAN H · 2014 to 2018
$3.2M
NHLBI NIH HHS R01 HL096875NHLBI NIH HHS R01HL096875NIDDK NIH HHS P30 DK035816NIDDK NIH HHS P30DK035816NIDDK NIH HHS R01 DK088762NIDDK NIH HHS R01DK088762NIDDK NIH HHS R01 DK099199NIDDK NIH HHS R01DK099199
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

24,25-Dihydroxyvitamin D 3Diabetes MellitusFemaleGlomerular Filtration RateHumansKidney Failure, ChronicMaleObservational Studies as TopicRandomized Controlled Trials as Topic24,25-Dihydroxyvitamin D 3

Identifiers

PMID27091017
PMCPMC5771237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.